KaliVir and Roche Enters into a Global Licensing Agreement to Discover, Develop and Commercialize Novel Oncolytic Vaccinia Viruses
Shots: KaliVir will receive an upfront payment & may be eligible to receive re...
Shots: KaliVir will receive an upfront payment & may be eligible to receive re...
Shots: CASI to receive a $10M up front, milestones along with royalty. Tianshi wil...
Shots: RQ Bio to receive up front & milestones of ~$157M along with royalties....
Shots: Evotec receives $200M upfront & an additional fee in performance-based,...
Shots: Twist to receive an up front & additional fees upon licensing...
Shots: Byondis to receive an up front & will also be eligible to receive an ad...
Incisive News in 3 Shots.